Sumitomo Pharma America, Inc.

Sumitomo Pharma America, Inc. (United States) has no DMF, CEP or site registration linked in our records. 9 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Sumitomo Pharma America, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sumitomo-pharma-america-inc

Overview

Sumitomo Pharma America, Inc. is a pharmaceutical company headquartered in Marlborough, United States.

FDA compliance signals

9 FDA enforcement records linked to this company.

  • 4832015-01-23

    Late submission of 15-day report

  • 4832011-12-09

    Contamination, chemical or physical change, deterioration

  • 4832011-12-09

    Investigations of discrepancies, failures

  • 4832011-04-20

    Contract drug products--lack of responsibility

  • 4832011-04-20

    Failure to meet specifications

  • 4832010-06-03

    Procedures to be written and followed

  • 4832010-06-03

    Investigations of discrepancies, failures

  • 4832009-09-01

    Late submission of quarterly safety reports

  • 4832009-09-01

    Failure to develop written procedures

For suppliers

Is this Sumitomo Pharma America, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.